Evaluation of chemotherapy response in osteosarcoma with FDG-PET

Annals of Nuclear Medicine

Volumn 23, Issue 1, 2009, Pages 89-95

  Hamada, Kenichiro ^b   Tomita, Yasuhiko ^a   Inoue, Atsuo ^b   Fujimoto, Tetsuho ^a   Hashimoto, Nobuyuki ^b   Myoui, Akira ^b   Yoshikawa, Hideki ^b   Hatazawa, Jun ^b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Osteosarcoma; Positron emission tomography

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; IFOSFAMIDE; METHOTREXATE;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CISPLATIN; DOXORUBICIN; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IFOSFAMIDE; MALE; METHOTREXATE; MIDDLE AGED; OSTEOSARCOMA; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 60349087299     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-008-0213-5     Document Type: Article

References (22)

1. G. Bacci A. Longhi M. Versari M. Mercuri A. Briccoli P. Picci 2006 Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution Cancer 106 1154 1161
2. M.P. Link A.M. Goorin A.W. Miser A.A. Green C.B. Pratt J.B. Belasco 1986 The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity N Engl J Med 314 1600 1606
3. A.M. Davis R.S. Bell P.J. Goodwin 1994 Prognostic factors in osteosarcoma: a critical review J Clin Oncol 12 423 431
4. D.S. Hawkins J.G. Rajendran E.U. Conrad III J.D. Bruckner J.F. Eary 2002 Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography Cancer 94 3277 3284
5. J. Smith R.T. Heelan A.G. Huvos B. Caparros G. Rosen C. Urmacher 1982 Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy: radiological-pathological correlation in 63 patients Radiology 143 355 360
6. J.A. Lawrence P.S. Babyn H.S. Chan P.S. Thorner G.E. Pron I.J. Krajbich 1993 Extremity osteosarcoma in childhood: prognostic value of radiologic imaging Radiology 189 43 47
7. M. Schulte D. Brecht-Krauss B. Heymer A. Guhlmann E. Hartwig M.R. Sarkar 2000 Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET J Nucl Med 41 1695 1701
8. A.C. Kole O.E. Nieweg H.J. Hoekstra J.R. van Horn H.S. Koops W. Vaalburg 1998 Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors J Nucl Med 39 810 815
9. C. Franzius S. Bielack S. Flege J. Sciuk H. Jurgens O. Schober 2002 Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma J Nucl Med 43 1012 1017
10. C. Rousseau A. Devillers C. Sagan L. Ferrer B. Bridji L. Campion 2006 Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography J Clin Oncol 24 5366 5372
11. P. Bassa E.E. Kim T. Inoue F.C. Wong M. Korkmaz D.J. Yang 1996 Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer J Nucl Med 37 931 938
12. V.J. Lowe F.R. Dunphy M. Varvares H. Kim M. Wittry C.H. Dunphy 1997 Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography Head Neck 19 666 674
13. N.G. Mikhaeel M. Hutchings P.A. Fields M.J. O'Doherty A.R. Timothy 2005 FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma Ann Oncol 16 1514 1523
14. R. Kumar I. Maillard S.J. Schuster A. Alavi 2004 Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas Radiol Clin North Am 42 1083 1100
15. I. Gayed T. Vu R. Iyer M. Johnson H. Macapinlac N. Swanston 2004 The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors J Nucl Med 45 17 21
16. I.J. Lewis M.A. Nooij J. Whelan M.R. Sydes R. Grimer P.C. Hogendoorn 2007 Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup J Natl Cancer Inst 99 112 128
17. W. Brenner K.H. Bohuslavizki J.F. Eary 2003 PET imaging of osteosarcoma J Nucl Med 44 930 942
18. W.A. Murphy Jr 1991 Imaging bone tumors in the 1990s Cancer 67 1169 1176
19. M. Uhl U. Saueressig G. Koehler U. Kontny C. Niemeyer W. Reichardt 2006 Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas Pediatr Radiol 36 1306 1311
20. R.B. Sanchez S.F. Quinn A. Walling J. Estrada H. Greenberg 1990 Musculoskeletal neoplasms after intraarterial chemotherapy: correlation of MR images with pathologic specimens Radiology 174 237 240
21. D.S. Hawkins S.M. Schuetze J.E. Butrynski J.G. Rajendran C.B. Vernon E.U. Conrad III 2005 [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors J Clin Oncol 23 8828 8834
22. T. Kunisada T. Ozaki A. Kawai S. Sugihara K. Taguchi H. Inoue 1999 Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: angiography compared with thallium-201 scintigraphy Cancer 86 949 956